| NAME |
TERBINAFINE HCL 125MG/PKT GRNL,ORAL |
| VA GENERIC NAME |
TERBINAFINE |
| DOSAGE FORM |
GRNL,RCNST-ORAL |
| FDA MED GUIDE |
Terbinafine_Oral_Granules_(Lamisil)_(2019).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
125 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2017-02-15 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
TERBINAFINE GRNL,RCNST-ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
TERBINAFINE HCL 125MG/PKT ORAL GRNL |
| VA PRODUCT IDENTIFIER |
T0680 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4027399 |
| EFFECTIVE DATE/TIME |
-
- 2008-05-15 00:00:00
- STATUS: ACTIVE
|
